Wegovy 0.25 MG/0.5 ML pen 0.5ML
Ended Awarded Last action
- Contract number
- SPE2DR26F9DDF
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $15,735
Award facts
- Contract value 100% obligated
- $15,735.44 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $15,735.44 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Wegovy 0.25 mg/0.5 mL pen injections on January 13, 2026, with completion targeted for January 14, 2026. The order will be fulfilled at the contractor's facility in Conshohocken, Pennsylvania. This delivery order was awarded without set-aside restrictions through open competition, demonstrating the contractor's capability to meet federal pharmaceutical procurement requirements. AmerisourceBergen Drug Corp, a major pharmaceutical distributor, operates as a subsidiary of parent company Cencora, Inc. (doing business as AmerisourceBergen), both registered in the System for Award Management as critical vendors for federal medical supply needs.
This task order was issued under AmerisourceBergen's substantial Indefinite Delivery Contract with DLA Troop Support Medical valued at up to $999,999,999.00 through December 2026. The underlying IDC serves as a comprehensive global pharmaceutical support vehicle enabling the contractor to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including specialty medications, brand-name and generic drugs, vaccines, and related medical commodities. The DLA Medical Supply Chain relies on such prime vendor contracts to ensure efficient delivery of essential pharmaceutical products to military treatment facilities, the Defense Health Agency, and other federal healthcare systems.
Quick answers
Who was awarded contract SPE2DR26F9DDF?
SPE2DR26F9DDF was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 13, 2026.
How much is contract SPE2DR26F9DDF worth?
The government has obligated $15,735 on SPE2DR26F9DDF.
Is contract SPE2DR26F9DDF an order under another contract?
Yes. SPE2DR26F9DDF is a delivery order under SPE2DR25D1017, an indefinite delivery contract.
Was contract SPE2DR26F9DDF competed?
The extent of competition for SPE2DR26F9DDF was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award